Novo Nordisk to Use Linguamatics Text Mining Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Linguamatics today said that the diabetes care company Novo Nordisk will use its text mining and natural language processing software.

Under a multi-year agreement, the Cambridge, UK-based company said that Novo Nordisk will use its I2E to mine published literature and internal information sources to provide intelligence for making research and development decisions. Linguamatics COO Roger Hale said in a statement that the I2E platform can be used to "deliver value for questions ranging from R&D to business and competitor intelligence."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.